Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Schousboe, Mette L ^a   Rajakaruna, Rupika S ^b   Salanti, Ali ^a   Hapuarachchi, Hapuarachchige C ^c   Galappaththy, Gawrie N L ^d   Bygbjerg, Ib C ^a   Amerasinghe, Priyanie H ^e   Konradsen, Flemming ^a   Alifrangis, Michael ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

^c UNIVERSITY OF COLOMBO   (Sri Lanka)

^d MINISTRY OF HEALTH   (Sri Lanka)

^e INTERNATIONAL WATER MANAGEMENT INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; CODON; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME POLYMORPHISM; GENE MUTATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IN SITU HYBRIDIZATION; MALARIA; MICROBIAL DIVERSITY; MUTATION RATE; NONHUMAN; OLIGONUCLEOTIDE PROBE; PARASITE ISOLATION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROTOZOAL GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; SRI LANKA;

ANIMALS; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRIMETHAMINE; SRI LANKA; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 33947517928     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-28     Document Type: Article

References (20)

1. The neglected burden of Plasmodium vivax malaria. K Mendis BJ Sina P Marchesini R Carter, Am J Trop Med Hyg 2001 64 97 106 11425182
2. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. S Pukrittayakamee M Imwong S Looareesuwan NJ White, Acta Trop 2004 89 351 356 10.1016/j.actatropica.2003.10.012 14744561
3. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. P Eldin LK Basco R Tahar T Ouatas A Mazabraud, Gene 1998 211 177 185 10.1016/S0378-1119(98)00118-8 9573357
4. Dihydrofolate Reductase Mutations in Plasmodium vivax from Indonesia and Therapeutic Response to Sulfadoxine Plus Pyrimethamine. MD Hastings KM Porter JD Maguire I Susanti W Kania MJ Bangs SC Hopkins JK Baird, J Infect Dis 2004 189 744 750 10.1086/381397 14767830
5. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. JG Kublin FK Dzinjalamala DD Kamwendo EM Malkin JF Cortese LM Martino RA Mukadam SJ Rogerson AG Lescano ME Molyneux PA Winstanley P Chimpeni TE Taylor CV Plowe, J Infect Dis 2002 185 380 388 10.1086/338566 11807721
6. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. MD Hastings JD Maguire MJ Bangs PA Zimmerman JC Reeder JK Baird CH Sibley, Antimicrob Agents Chemother 2005 49 733 740 15673758 10.1128/AAC.49.2.733-740.2005
7. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. M Imwong S Pukrittayakamee L Renia F Letourneur JP Charlieu U Leartsakulpanich S Looareesuwan NJ White G Snounou, Antimicrob Agents Chemother 2003 47 1514 1521 12709316 10.1128/AAC.47.5.1514-1521.2003
8. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. E Tjitra J Baker S Suprianto Q Cheng NM Anstey, Antimicrob Agents Chemother 2002 46 3947 3953 12435700 10.1128/AAC.46.12.3947-3953.2002
9. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. M Korsinczky K Fischer N Chen J Baker K Rieckmann Q Cheng, Antimicrob Agents Chemother 2004 48 2214 2222 15155224 10.1128/AAC.48.6.2214-2222.2004
10. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. M Imwong S Pukrittayakamee Q Cheng C Moore S Looareesuwan G Snounou NJ White NP Day, Antimicrob Agents Chemother 2005 49 4393 4395 16189131 10.1128/AAC.49.10.4393-4395.2005
11. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine- pyrimethamine in Sri Lanka. HC Hapuarachchi MY Dayanath KB Bandara S Abeysundara W Abeyewickreme NR de Silva SY Hunt CH Sibley, Am J Trop Med Hyg 2006 74 198 204 16474070
12. A simple high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum cloroquine resistance transporter genes using ploymerase chain reaction and enzyme linked immunosorbent assay-based technology. M Alifrangis S Enosse R Pearce C Drakeley C Roper IF Khalil WM Nkya AM Ronn TG Theander IC Bygbjerg, Am J Trop Med Hyg 2005 72 155 162 15741552
13. Household responses to malaria and their costs: a study from rural Sri Lanka. F Konradsen HW Van der PH Amerasinghe FP Amerasinghe KT Fonseka, Trans R Soc Trop Med Hyg 1997 91 127 130 10.1016/S0035-9203(97)90194-2 9196747
14. Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia. PE de Pecoulas R Tahar P Yi KH Thai LK Basco, Acta Trop 2004 92 1 6 10.1016/j.actatropica.2004.03.011 15301969
15. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. M Imwong S Pukrittakayamee S Looareesuwan G Pasvol J Poirreiz NJ White G Snounou, Antimicrob Agents Chemother 2001 45 3122 3127 11600366 10.1128/AAC.45.11.3122- 3127.2001
16. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. PE de Pecoulas R Tahar T Ouatas A Mazabraud LK Basco, Mol Biochem Parasitol 1998 92 265 273 10.1016/S0166-6851(97)00247-8 9657331
17. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent. S Kaur SK Prajapati K Kalyanaraman A Mohmmed H Joshi VS Chauhan, Acta Trop 2006 97 174 180 10.1016/j.actatropica.2005.10.003 16310156
18. The role of private drug vendors as malaria treatment providers in selected malaria endemic areas of Sri Lanka. RS Rajakaruna M Weerasinghe M Alifrangis PH Amerasinghe F Konradsen, J Vector Borne Dis 2006 43 58 65 16967817
19. Tolerance is the key to understanding antimalarial drug resistance. IM Hastings WM Watkins, Trends Parasitol 2006 22 71 77 10.1016/j.pt.2005.12.011 16406706
20. Sri Lanka malaria maps. OJ Briet DM Gunawardena HW Van der FP Amerasinghe, Malar J 2003 2 22 12914667 10.1186/1475-2875-2-22